The Venture Codex Logo

The Venture Codex

Black Granite Capital

445 Hamilton Avenue Suite 1102, White Plains, NY, 10601, United States

Overview

Black Granite Capital invests in fast growing companies in healthcare and technology. Black Granite Capital makes growth equity investments in companies with products on the market, rapidly growing revenues, a significant competitive advantage and experienced management teams.

Total investments
4
Lead investments
3
Investments · 12mo
0
Active investors
2
Visit website

Investment portfolio

  • Jump Technologies

    Led · Series B · Nov 2018

    Jump Technologies is an Eagan, Minn.-based hospital supply chain solutions provider led by CEO John Freund. The company offers JumpStock, a cloud-based hospital supply chain software solution that integrates with any ERP system. JumpStock integrates into clinical workflows and delivers reports that allow clinicians and supply-chain professionals to make informed decisions about supply utilization across facilities, including high-cost areas such as operating and procedure rooms. The platform enables hospitals to standardize supply utilization, save money, and reallocate funds to clinical resources and technology while ensuring clinicians have the right supplies when and where needed. The company plans to use recent funding to expand its national sales and product development efforts. Jump Technologies is an Eagan, MN-based software company that provides cloud-based supply chain solutions for health systems. Its offerings include JumpStock Inventory Management and InnerTrack Receiving & Package Tracking, which automate supply management from demand through use and replenishment. The solutions are designed to reduce overstocking, stock-outs, hoarding and waste while increasing inventory turns, enabling data-driven decision making and improving forecasting and planning. The company is led by CEO John Freund. Jump closed a $3.5M funding round from Black Granite Capital LLC and intends to use the funds to expand and enhance its solutions and to grow its sales, customer success, development and quality assurance teams.

  • Bluesight

    Participated · Series C · Jun 2016

    Bluesight develops Medication Intelligence™ solutions that bring visibility and predictability to medication management, including KitCheck™ (RFID-enabled kit and tray management), ControlCheck™ (controlled substance diversion management) and CostCheck™ (drug purchasing optimization). Led by CEO Kevin MacDonald, the company applies AI and machine learning to surface actionable analytics that help health systems improve efficiency, reduce medication costs, and increase compliance and safety. More than 1,000 U.S. and Canadian hospitals use its solutions. Bluesight received a strategic growth investment from Thoma Bravo; the amount was not disclosed. The company intends to use the funds to further enhance drug diversion prevention through its acquisition of Medacist and to grow its inventory management and spend optimization offerings. The acquisition of Medacist will combine auditing capabilities and reporting tools to serve more than 2,000 hospitals across North America, providing unified visibility into medication usage and diversion. Kit Check offers cloud-based and Internet of Things (IoT) software to automate hospital pharmacy kit processing, medication tracking, and restocking, replacing manual processes. The company serves over 250 hospital pharmacies with 15,000 users across the United States and Canada. Led by co-founder and CEO Kevin MacDonald, Kit Check plans to use new funding to expand market share and extend its solutions. The company is based in Washington, DC. Kit Check has raised $37.4M to date, including the most recent round. The product focus is on reducing time-consuming and error-prone manual medication handling in hospitals. Kit Check is a Washington, D.C.-based provider of hospital pharmacy kit processing and medication tracking software. Its products include Kit Check for automated pharmacy kit medication restocking and Anesthesia Check for automated anesthesia medication tracking, validation and syringe-level recording. The company serves approximately 145 hospital pharmacies across the United States. Founded in 2012 by CEO Kevin MacDonald, Kit Check has raised $22.4M to date. It intends to use the new funds to further extend its product portfolio and drive customer growth. As part of the financing, Dave Schulte of Kaiser Permanente Ventures will join Kit Check’s board. Kit Check offers a cloud-based software platform paired with RFID-outfitted scanning stations to automate inventory of hospital pharmacy kits (code trays, crash carts, anesthesiology kits). The company says its scans can cut manual processing from 30+ minutes to about 3 minutes and that several customers have reduced out-of-date kit rates from roughly 20% to under 1%. Its system can be installed in less than one hour and requires no on-site installation or in-house IT support. Customers include the University of Maryland Medical Center, NYU Langone Medical Center and five other paying hospitals, with nine more hospitals expected to begin rollouts in the coming months. Kit Check graduated Rock Health’s accelerator with $100K in seed capital. The startup plans to use new funding to accelerate growth and expand its sales force and delivery staff. Kit Check positions its use of RFID, rather than barcodes, as a primary differentiator vs. competitors such as MedKeeper.

  • Hospital IQ

    Led · Equity · Mar 2015

    Hospital IQ offers a cloud-based operations management platform that combines advanced data analytics, machine learning and simulation technology with an intuitive user interface to optimize surgical resource alignment, patient flow, and staff scheduling. Its AI-enabled platform integrates predictive analytics, workflows and communications to drive measurable operational improvements for hospitals and health systems. The company says hundreds of hospitals and health systems rely on its software and that it has become an industry standard in capacity operations management and optimization. Hospital IQ reported a record year in which revenue more than doubled, its customer base grew by 50%, and platform utilization increased 14x. The company plans to use new funding to accelerate product development, sales and marketing, client services, and to expand partnerships including Allscripts and Cerner. Hospital IQ also intends to hire aggressively, targeting 50% headcount growth by year-end and 100% growth within the next 12 months. PatientRoute Systems builds a predictive analytics platform used by hospitals and surgical centers to detect operational patterns and help reduce readmissions, shorten length of stay, improve on-time surgery starts, and reduce turnover time. The platform is aimed at analysts and department heads and is designed to support hospital clinical policy. The company currently serves clients across six states and focuses on hospitals and surgical centers with more than 400 beds. Customers include Greater Baltimore Medical Center and Boston Medical Center. PatientRoute was founded by CEO Rich Krueger in 2013 and is based in Boston. It raised $7 million to expand its platform and plans to use the capital to double its 12-person team, ideally by the end of the year.

Team